Company Opiant Pharmaceuticals, Inc.
Equities
OPNT
US6837501039
Biotechnology & Medical Research
Business Summary
Number of employees: 38
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ryan Preblick
DFI | Director of Finance/CFO | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,268,677 | 4,860,817 ( 92.26 %) | 0 | 92.26 % |
Company contact information
Opiant Pharmaceuticals, Inc.
10710 Midlothian Turnpike Suite 125
23235, Richmond
+
https://www.opiant.comSector
1st Jan change | Capi. | |
---|---|---|
+19.44% | 125B | |
+20.01% | 114B | |
+22.07% | 26.73B | |
-23.72% | 19.43B | |
-18.14% | 16.22B | |
-19.87% | 15.33B | |
+55.81% | 14.2B | |
+8.76% | 14.42B | |
-48.79% | 14.33B |